Joosten I - Search Results

1

A single dose of rituximab does not deplete B cells in secondary lymphoid organs but alters phenotype and function.

Kamburova EG, Koenen HJ, Borgman KJ, ten Berge IJ, Joosten I, Hilbrands LB. Kamburova EG, et al. Among authors: joosten i. Am J Transplant. 2013 Jun;13(6):1503-11. doi: 10.1111/ajt.12220. Epub 2013 Apr 9. Am J Transplant. 2013. PMID: 23570303 Free article.

2

Fine tuning of antigen-presenting cell-directed monoclonal antibody strategies in the induction of human allospecific T-cell tolerance in vitro.

Koenen HJ, Joosten I. Koenen HJ, et al. Among authors: joosten i. Transplant Proc. 1998 Aug;30(5):2447-9. doi: 10.1016/s0041-1345(98)00681-2. Transplant Proc. 1998. PMID: 9723532 No abstract available.

3

Blockade of CD86 and CD40 induces alloantigen-specific immunoregulatory T cells that remain anergic even after reversal of hyporesponsiveness.

Koenen HJ, Joosten I. Koenen HJ, et al. Among authors: joosten i. Blood. 2000 May 15;95(10):3153-61. Blood. 2000. PMID: 10807782 Free article.

4

Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis.

Koenen HJ, Michielsen EC, Verstappen J, Fasse E, Joosten I. Koenen HJ, et al. Among authors: joosten i. Transplantation. 2003 May 15;75(9):1581-90. doi: 10.1097/01.TP.0000053752.87383.67. Transplantation. 2003. PMID: 12792519

5

IL-15 and cognate antigen successfully expand de novo-induced human antigen-specific regulatory CD4+ T cells that require antigen-specific activation for suppression.

Koenen HJ, Fasse E, Joosten I. Koenen HJ, et al. Among authors: joosten i. J Immunol. 2003 Dec 15;171(12):6431-41. doi: 10.4049/jimmunol.171.12.6431. J Immunol. 2003. PMID: 14662842

6

A novel bispecific antihuman CD40/CD86 fusion protein with t-cell tolerizing potential.

Koenen HJ, den Hartog MT, Heerkens S, Fasse E, Ortiz-Buijsse A, van Neerven RJ, Simons PJ, Joosten I, Boon L. Koenen HJ, et al. Among authors: joosten i. Transplantation. 2004 Nov 27;78(10):1429-38. doi: 10.1097/01.tp.0000140481.41441.63. Transplantation. 2004. PMID: 15599306

7

Tolerizing effects of co-stimulation blockade rest on functional dominance of CD4+CD25+ regulatory T cells.

Coenen JJ, Koenen HJ, van Rijssen E, Hilbrands LB, Joosten I. Coenen JJ, et al. Among authors: joosten i. Transplantation. 2005 Jan 27;79(2):147-56. doi: 10.1097/01.tp.0000147460.93587.87. Transplantation. 2005. PMID: 15665762

8

CD27/CFSE-based ex vivo selection of highly suppressive alloantigen-specific human regulatory T cells.

Koenen HJ, Fasse E, Joosten I. Koenen HJ, et al. Among authors: joosten i. J Immunol. 2005 Jun 15;174(12):7573-83. doi: 10.4049/jimmunol.174.12.7573. J Immunol. 2005. PMID: 15944257

9

Cyclosporine preserves the anergic state of human T cells induced by costimulation blockade in vitro.

Koenen HJ, Fasse E, Joosten I. Koenen HJ, et al. Among authors: joosten i. Transplantation. 2005 Aug 27;80(4):522-9. doi: 10.1097/01.tp.0000172217.97072.54. Transplantation. 2005. PMID: 16123728

10

Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells.

Coenen JJ, Koenen HJ, van Rijssen E, Hilbrands LB, Joosten I. Coenen JJ, et al. Among authors: joosten i. Blood. 2006 Feb 1;107(3):1018-23. doi: 10.1182/blood-2005-07-3032. Epub 2005 Oct 6. Blood. 2006. PMID: 16210336 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters